Rapid, Selective, and Sensitive LC-MS/MS Method Determines Antioxidant Level in Blood Plasma.
News Jun 06, 2017 | by Adam Tozer PhD
A small team of scientists from China’s Heibei University have developed an LC-MS/MS method for assessing blood plasma concentrations of an antioxidant isolated from paeonies that has been suggested to have therapeutic implications in the treatment of Alzheimer’s Disease.
Benzoylpaeoniflorin (BP) is a potential therapeutic agent against the oxidative stress underlying the neurodegeneration seen in Alzheimer's disease.
In this study, a more rapid, selective, and sensitive liquid chromatography-tandem mass spectrometric (LC-MS/MS) method was developed to determine BP in rat plasma, distinguishing it from the similar monoterpene isomer, benzoylalbiflorin (BA).
The method showed a linear response from 1 to 1000 ng/mL (r > 0.9950). The precision of the interday and intraday ranged from 2.03 to 12.48% and the accuracy values ranged from −8.00 to 10.33%.
Most importantly, the method could be run and finished in 4 minutes.
The LC-MS/MS method was validated for specificity, linearity, precision, accuracy, recovery, and stability and was found to be acceptable for bioanalytical application. As a final test, the fully validated method was successfully applied to a pharmacokinetic study in rats following oral administration.
Zhou, C. and Wang, X. (2017). Rapid Determination of Isomeric Benzoylpaeoniflorin and Benzoylalbiflorin in Rat Plasma by LC-MS/MS Method. International Journal of Analytical Chemistry, 2017, pp.1-9.
Rapid and Cost-Effective Instrument that Measures Molecular DynamicsNews
By combining mass spectrometry and thermal desorption, researchers honed a new method to measure excitation and relaxation rates of uracil, the building block of RNA.READ MORE
Broadly Acting Antibodies Found in Blood of Ebola SurvivorsNews
Scientists have discovered a set of powerful, broadly neutralizing antibodies in the blood of Ebola survivors. In animal studies, two of these antibodies provided substantial protection against disease caused by the three species known to cause fatal human illness.READ MORE
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019